Feedback    Advertise    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum
Nutrient Supplementation Strategies for Biopharmaceutical Production, Part 2
Richard Fike
BioProcess International, Vol. 7, No. 11, December 2009, pp. 46–52
 
Protein Production Enhancers

A number of small-molecule protein production enhancers work through various metabolic pathways to inhibit cell expansion, thus switching cells into a production phase. These molecules tend to be somewhat cytotoxic, supposedly working through stimulation of apoptotic pathways, so their use must be assessed for each cell line. But these enhancers have been known to double productivity.

Several mechanisms of butyrate action have been suggested such as enhanced gene transcription through gene accessibility stimulation (47). In one study, sodium butyrate and sodium propionate (an alkanoic acid) enhanced MAb production sixfold (48). Whereas butyrate showed toxicity, no cell inhibition was seen with propionate. Similar results were reported comparing pentanoic acid (a carboxylic acid) with butyrate (49).

Another study tested valproic acid (which is both FDA approved and much less expensive than butyrate) as an alternative to butyrate (50). Productivity improvements were observed. Seeking new protein-inducing compounds, Allen et al. used a high-throughput model for screening chemical libraries to identify several basic types of molecules as potential possibilities (51). Cell transcriptional activity helped in the team's search and points to use of molecular approaches in future efforts.

In a different mode, adenosine 5′-monophosphate (AMP) significantly increased hepatitis B surface antigen production in CHO cells but dramatically reduced cell number once added to a culture (52). Extracellular nucleotides were shown to enhance protein production because intracellular adenosine 5′-triphosphate (ATP) pools increased with AMP addition. Yet another study showed rapamycin (a G1-phase arresting agent that slows cell cycle progression to delay apoptosis) to reduce hybridoma cell death and enhance MAb production twofold in fed-batch cultures (53). Dimethyl sulfoxide (DMSO) has also been advocated as a protein-inducing enhancer. Ling et al. showed that 0.2% DMSO added to hybridoma cultures at maximum cell density doubled MAb production with no negative effect on bioactivity and glycosylation (54).

The Next Step

As reviewed here, different nutrient supplements and feeding strategies can improve cell performance. Once basic cell culture parameters have been optimized, nutrient supplementation can usually result in a doubling or greater of cell productivity. The conclusion of this three-part review will examine scale-up and scale-down strategies for rapid nutrient supplement prototyping.

REFERENCES
1.) Fike, R. 2009. Nutrient Supplementation Strategies for Biopharmaceutical Production, Part 1: Identifying a Nutrient Supplementation Formulation. BioProcess Int. 7:44-51.

2.) Fike, R. 1993. Feeding Strategies for Enhanced Hybridoma Productivity: Automated Concentrate Supplementation. BioPharm 6:49-54.

3.) Wlaschin, K, and W-S. Hu. 2006. Fedbatch Culture and Dynamic Nutrient Feeding. Adv. Biochem. Engin./Biotechnol. 101:43-74.

4.) Zhou, W.. 1997. Fed-Batch Culture of Recombinant NS0 Myeloma Cells with High Monoclonal Antibody Production. Biotechnol. Bioeng. 55:783-792.

5.) Sauer, P. 2000. A High-Yielding, Generic Fed-Batch Cell Culture Process for Production of Recombinant Antibodies. Biotechnol. Bioeng. 67:585-597.

6.) Xie, L, and D. Wang. 2006. Fed-Batch Cultivation of Animal Cells Using Different Medium Design Concepts and Feeding Strategies. Biotechnol. Bioeng. 95:270-284.

7.) Spens, E, and L. Haggstrom. 2007. Defined Protein and Animal Component-Free NS0 Fed-Batch Culture. Biotechnol. Bioeng. 98:1183-1194.

8.) Sandadi, S. 2006. Application of Fractional Factorial Designs to Screen Active Factors for Antibody Production By Chinese Hamster Ovary Cells. Biotechnol. Prog. 22:595-600.

9.) Sitton, G, and F. Srienc. 2008. Mammalian Cell Culture Scale-Up and Fed-Batch Control Using Automated Flow Cytometry. J. Biotechnol. 135:174-180.

10.) deZengotita, V. 2000. Phosphate Feeding Improves High-Cell-Concentration NSO Myeloma Culture Performance for Monoclonal Antibody Production. Biotechnol. Bioeng. 69:566-576.

11.) Konstantinov, K. 2006. The “Push-to-Low” Approach for Optimization of High-Density Perfusion Cultures of Animal Cells. Adv. Biochem. Engin./Biotechnol. 101:75-98.

12.) Senger, R, and M. Karim. 2007. Optimization of Fed-Batch Parameters and Harvest Time of CHO Cell Cultures for a Glycosylated Product with Multiple Mechanisms of Inactivation. Biotechnol. Bioeng. 98:378-390.

13.) Takagi, M. 2001. Effects of High Concentrations of Energy Sources and Metabolites on Suspension Culture of Chinese Hamster Ovary Cells Producing Tissue Plasminogen Activator. J. Biosci. Bioeng. 91:515-521.

14.) Baldi, L. 2007. Recombinant Protein Production By Large-Scale Transient Gene Expression in Mammalian Cells: State of the Art and Future Perspectives. Biotechnol. Lett. 29:677-684.

15.) Sun, X. 2006. Enhancement of Transient Gene Expression By Fed-Batch Culture of HEK 293 EBNA1 Cells in Suspension. Biotechnol. Lett. 28:843-848.

16.) Dempsey, J. 2003. Improved Fermentation Processes for NSO Cell Lines Expressing Human Antibodies and Glutamine Synthetase. Biotechnol. Prog. 19:175-178.

17.) Zeng, A-P. 1998. Variation of Stoichiometric Ratios and Their Correlation for Monitoring and Control of Animal Cell Cultures. Biotechnol. Prog. 14:434-441.

18.) Fassnacht, D. 1997. Influence of Non-Essential Amino Acids on Apoptotic and Necrotic Death of Mouse Hybridoma Cells in Batch Cultures. Biotech. Lett. 19:35-38.

19.) Burky, J. 2007. Protein-Free Fed-Batch Culture of Non-GS NSO Cell Lines for Production of Recombinant Antibodies. Biotechnol. Bioeng. 96:281-293.

20.) Gambhir, A. 1999. Alteration of Cellular Metabolism By Consecutive Fed-Batch Cultures of Mammalian Cells. J. Biosci. Bioeng. 87:805-810.

21.) Wlaschin, K, and W-S. Hu. 2006. Fedbatch Culture and Dynamic Nutrient Feeding. Adv. Biochem. Engin./Biotechnol. 101:43-74.

22.) Maranga, L, and C. Goochee. 2006. Metabolism of PER.C6™ Cells Cultivated Under Fed-Batch Conditions at Low Glucose and Glutamine Levels. Biotechnol. Bioeng. 94:139-150.

23.) Lee, Y. 2003. Low-Glutamine Fed-Batch Cultures of 293-HEK Serum-Free Suspension Cells for Adenovirus Production. Biotechnol. Prog. 19:501-509.

24.) Li, L. 2005. Increasing the Culture Efficiency of Hybridoma Cells By the Use of Integrated Metabolic Control of Glucose and Glutamine at Low Levels. Biotechnol. Appl. Bioehem. 42:73-80.

25.) Vriezen, N. 1997. Effects of Glutamine Supply on Growth and Metabolism of Mammalian Cells in Chemostat Culture. Biotechnol. Bioeng. 54:272-286.

26.) Gambhir, A. 2003. Analysis of Cellular Metabolism of Hybridoma Cells at Distinct Physiological States. J. Biosci. Bioeng. 95:317-327.

27.) Kuwae, S. 2005. Development of a Fed-Batch Culture Process for Enhanced Production of Recombinant Human Antithrombin By Chinese Hamster Ovary Cells. J. Biosci. Bioeng. 100:502-510.

28.) Yeo, J. 2006. Glutamine or Glucose Starvation in Hybridoma Cultures Induces Death Receptor and Mitochondrial Apoptotic Pathways. Biotechnol. Lett. 28:1445-1452.

29.) Hwang, S, and G. Lee. 2008. Nutrient Deprivation Induces Autophagy as well as Apoptosis in Chinese Hamster Ovary Cell Culture. Biotechnol. Bioeng. 99:678-685.

30.) Altamirano, C. 2001. Decoupling Cell Growth and Product Formation in Chinese Hamster Ovary Cells Through Metabolic Control. Biotechnol. Bioeng. 76:351-360.

31.) Altamirano, C. 2001. Analysis of CHO Cells Metabolic Redistribution in a Glutamate-Based Defined Medium in Continuous Culture. Biotechnol. Prog. 17:1032-1041.

32.) Altamirano, C. 2004. Strategies for Fed-Batch Cultivation of t-PA Producing CHO Cells: Substitution of Glucose and Glutamine and Rational Design of Culture Medium. J. Biotechnol. 110:171-179.

33.) Miller, W. 1988. A Kinetic Analysis of Hybridoma Growth and Metabolism in Batch and Continuous Suspension Culture: Effect of Nutrient Concentration, Dilution Rate, and pH. Biotechnol. Bioeng. 32:947-965.

34.) Yoon, S. 2004. Effect of Simultaneous Application of Stressful Culture Conditions on Specific Productivity and Heterogeneity of Erythropoietin in Chinese Hamster Ovary Cells. Biotechnol. Prog. 20:1293-1296.

35.) Sandadi, S. 2005. Heuristic Optimization of Antibody Production By Chinese Hamster Ovary Cells. Biotechnol. Prog. 21:1537-1542.

36.) Osman, J. 2001. The Response of GS-NSO Myeloma Cells to pH Shifts and pH Perturbations. Biotechnol. Bioeng. 75:63-73.

37.) Gramer, M, and T. Ogorzalek. 2007. A Semi-Empirical Mathematical Model Useful for Describing the Relationship Between Carbon Dioxide, pH, Lactate and Base in a Bicarbonate-Buffered Cell-Culture Process. Biotechnol. Appl. Biochem. 47:197-204.

38.) Fox, S. 2004. Maximizing Interferon-γ Production By Chinese Hamster Ovary Cells Through Temperature Shift Optimization: Experimental and Modeling. Biotechnol. Bioeng. 85:177-184.

39.) Fogolin, M. 2004. Impact of Temperature Reduction and Expression of Yeast Pyruvate Carboxylase on hGM-CSF-Producing CHO Cells. J. Biotechnol. 109:179-191.

40.) Yoon, S. 2003. Effect of Low Culture Temperature on Specific Productivity and Transcription Level of Anti-4-1BB Antibody in Recombinant Chinese Hamster Ovary Cells. Biotechnol. Prog. 19:1383-1386.

41.) Yoon, S. 2007. Effect of Culture Temperature on Follicle-Stimulating Hormone Production By Chinese Hamster Ovary Cells in a Perfusion Bioreactor. Appl. Microbiol. Biotechnol. 76:83-89.

42.) Takuma, S. 2007. Dependence on Glucose Limitation of the pCO2 Influences on CHO Cell Growth, Metabolism and IgG Production. Biotechnol. Bioeng. 97:1479-1488.

43.) Goudar, C. 2007. Decreased pCO2 Accumulation By Eliminating Bicarbonate Addition to High Cell-Density Cultures. Biotechnol. Bioeng. 96:1107-1117.

44.) Hu, W-S, and J. Aunins. 1997. Large-Scale Mammalian Cell Culture. Curr. Opin. Biotechnol. 8:148-153.

45.) Xing, Z. 2008. Identifying Inhibitory Threshold Values of Repressing Metabolites in CHO Cell Culture Using Multivariate Analysis Methods. Biotechnol. Prog. 24:675-683.

46.) Prentice, H. 2007. Improving Performance of Mammalian Cells in Fed-Batch Processes Through “Bioreactor Evolution.”. Biotechnol. Prog. 23:458-464.

47.) Jiang, Z, and S. Sharfstein. 2008. Sodium Butyrate Stimulates Monoclonal Antibody Over-Expression in CHO Cells By Improving Gene Accessibility. Biotechnol. Bioeng. 100:189-194.

48.) Chun, B-H. 2003. Enhanced Production of Recombinant B-Domain Deleted Factor VIII from Chinese Hamster Ovary Cells By Propionic and Butyric Acids. Biotech. Lett. 25:315-319.

49.) Liu, C-H. 2001. Pentanoic Acid, a Novel Protein Synthesis Stimulant for Chinese Hamster Ovary (CHO) Cells. J. Biosci. Bioeng. 91:71-75.

50.) Backliwal, G. 2008. Valproic Acid: A Viable Alternative to Sodium Butyrate for Enhancing Protein Expression in Mammalian Cell Cultures. Biotechnol. Bioeng. 101:182-189.

51.) Allen, M. 2008. Identification of Novel Small Molecule Enhancers of Protein Production By Cultured Mammalian Cells. Biotechnol. Bioeng. 100:1193-1204.

52.) Luo, W. 2005. Enhancement of Hepatitis B Surface Antigen Production By Adenosine 5′-Monophosphate in Culture of Recombinant Chinese Hamster Ovary Cells. J. Bioscience Bioeng. 100:475-477.

53.) Balcarcel, R, and G. Stephanopoulos. 2001. Rapamycin Reduces Hybridoma Cell Death and Enhances Monoclonal Antibody Production. Biotechnol. Bioeng. 76:1-10.

54.) Ling, W. 2003. Improvement of Monoclonal Antibody Production in Hybridoma Cells by Dimethyl Sulfoxide. Biotechnol. Prog. 19:158-162.

 «PREVIOUS PAGE    1  |    2  |    3   |  
 
| | Share
The Best of GE Healthcare: Tools for vaccine processes

In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.

Register to download these two NEW application notes:

Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility

DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA


More Travel Tips from the Editor in Chief
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550